查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1957922

2026年全球玻尿酸注射疗法市场报告

Viscosupplementation Global Market Report 2026
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，关节内粘稠补充疗法市场发展迅速。预计该市场将从2025年的45亿美元成长到2026年的49.7亿美元，复合年增长率达10.4%。过去几年的成长归因于多种因素，例如骨关节炎盛行率的上升、老年人口的增加、关节治疗技术的进步、人们对关节内粘稠补充疗法的认识提高以及整形外科医疗基础设施的扩建。

预计未来几年关节内粘稠补充疗法市场将快速成长，到2030年将达到73.4亿美元，复合年增长率（CAGR）为10.2%。预测期内的成长要素包括再生医学的引入、数位健康监测的整合、新型透明质酸製剂的研发、门诊手术中心的扩张以及对门诊整形外科手术投资的增加。预测期内的主要趋势包括微创关节治疗、再生医学的整合、个人化骨关节炎治疗、注射玻尿酸的创新以及门诊整形外科手术。

预计未来几年，骨关节炎盛行率的不断上升将推动关节内粘稠补充疗法市场的扩张。骨关节炎是一种退化性关节疾病，当关节（尤其是髋关节、膝关节和手腕关节）开始劣化时就会发生；它是一种常见的关节炎。关节内粘稠补充疗法是将透明质酸直接注射到关节内，以缓解疼痛、促进骨骼平滑运动，并有助于减轻疼痛和改善关节功能。例如，根据美国非营利全球健康研究机构—健康指标与评估研究所 (IHME) 于 2023 年 8 月发布的报告，预计到 2050 年，膝关节骨关节炎的发生率将增加 75%，手部骨关节炎的发生率将增加 50%。因此，骨关节炎发生率的上升趋势正在推动关节内粘稠补充疗法市场的成长。

关节内粘稠补充疗法市场的主要企业正致力于开发创新产品，例如可吸收透明质酸支架。这些产品透过改善关节润滑、促进组织再生以及长期缓解骨关节炎症状，进而提升患者疗效并扩大治疗选择。可吸收透明质酸支架是由透明质酸（HA）製成的生物相容性且可生物降解的结构，透明质酸是一种天然存在于结缔组织中的多醣。例如，2023年5月，总部位于美国的整形外科专业公司Annika Therapeutics宣布推出Hyalofast，这是一种用于软骨修復的单步式即用型可吸收透明质酸支架。 Hyalofast提供了一种基于透明质酸的关节保护解决方案，并可能成为更具侵入性的外科手术的替代方案。

目录

第一章：执行摘要

第二章 市场特征

  • 市场定义和范围
  • 市场区隔
  • 主要产品和服务概述
  • 全球玻尿酸注射疗法市场：吸引力评分及分析
  • 成长潜力分析、竞争评估、策略适宜性评估、风险状况评估

第三章 市场供应链分析

  • 供应链与生态系概述
  • 清单：主要原料、资源和供应商
  • 主要经销商和通路合作伙伴名单
  • 主要最终用户列表

第四章：全球市场趋势与策略

  • 关键科技与未来趋势
    • 生物技术、基因体学、精准医疗
    • 工业4.0和智慧製造
    • 数位化、云端运算、巨量资料、网路安全
    • 人工智慧（AI）和自主人工智慧
    • 物联网、智慧基础设施、互联生态系统
  • 主要趋势
    • 微创关节治疗
    • 再生医学的整合
    • 骨关节炎的个人化治疗
    • 注射用玻尿酸的创新
    • 门诊整形外科手术

第五章 终端用户产业市场分析

  • 医院
  • 门诊手术中心
  • 整形外科诊所
  • 復健中心
  • 运动医学中心

第六章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税的影响、关税战和贸易保护主义对供应链的影响，以及 COVID-19 疫情对市场的影响。

第七章：全球策略分析架构、目前市场规模、市场对比及成长率分析

  • 全球玻尿酸注射疗法市场：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 全球玻尿酸注射疗法市场规模、对比及成长率分析
  • 全球玻尿酸注射疗法市场表现：规模与成长，2020-2025年
  • 全球玻尿酸注射疗法市场预测：规模与成长，2025-2030年，2035年预测

第八章：全球市场总规模（TAM）

第九章 市场细分

  • 按类型
  • 单剂量关节内粘稠补充疗法、三剂量关节内粘稠补充疗法、五剂量关节内粘稠补充疗法
  • 按来源
  • 鸟类来源的，非鸟类来源的
  • 透明质酸的类型
  • 标准玻尿酸，稳定型玻尿酸
  • 透过使用
  • 膝关节骨关节炎、髋关节骨关节炎、手指骨关节炎
  • 最终用户
  • 医院、门诊手术中心和其他最终用户
  • 按类型细分：单剂量关节内粘稠补充疗法
  • 含玻尿酸的产品，不含透明质酸的产品
  • 按类型细分：三次注射关节内粘稠补充疗法
  • 透明质酸类产品、复合产品
  • 按类型细分：5-关节内粘稠补充疗法
  • 透明质酸类产品、复合产品

第十章 区域与国别分析

  • 全球玻尿酸注射疗法市场：按地区划分，实际结果与预测，2020-2025年、2025-2030年预测、2035年预测
  • 全球玻尿酸注射疗法市场：按国家/地区划分，实际数据和预测数据，2020-2025年、2025-2030年预测数据、2035年预测数据

第十一章 亚太市场

第十二章：中国市场

第十三章：印度市场

第十四章：日本市场

第十五章：澳洲市场

第十六章：印尼市场

第十七章：韩国市场

第十八章 台湾市场

第十九章 东南亚市场

第20章 西欧市场

第21章英国市场

第22章：德国市场

第23章：法国市场

第24章：义大利市场

第25章：西班牙市场

第26章：东欧市场

第27章：俄罗斯市场

第28章 北美市场

第29章：美国市场

第三十章：加拿大市场

第31章：南美市场

第32章：巴西市场

第33章 中东市场

第34章：非洲市场

第三十五章 市场监理与投资环境

第36章：竞争格局与公司概况

  • 玻尿酸注射疗法市场：竞争格局及市场占有率（2024年）
  • 玻尿酸注射疗法市场：公司估值矩阵
  • 玻尿酸注射疗法市场：公司概况
    • Seikagaku Corporation
    • Anika Therapeutics Inc.
    • Bioventus LLC
    • Zimmer Biomet
    • Johnson & Johnson Services Inc.

第37章 其他大型企业和创新企业

  • Aptissen SA, Smith & Nephew Plc., Flexion Therapeutics Inc., Regen Lab SA, OrthogenRx Inc., Fidia Farmaceutici SPA, Ferring Pharmaceuticals, Laboratoires VIVACY, Allergan, Hyalgan, Synvisc, Euflexxa, Sanofi SA, Wellchem Pharmaceuticals Pte Ltd, Medtronic Inc.

第38章：全球市场竞争基准分析与仪錶板

第39章 重大併购

第四十章：高潜力市场国家、细分市场与策略

  • 2030年玻尿酸注射疗法市场：提供新机会的国家
  • 2030年玻尿酸注射疗法市场：充满新机会的细分市场
  • 2030年玻尿酸注射疗法市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手的策略

第41章附录

简介目录
Product Code: PH4MVISC01_G26Q1

Viscosupplementation is a process in which hyaluronic acid, a gel-like fluid, is injected directly into a joint. Synovial fluid, naturally present around joints, contains hyaluronic acid, which helps reduce friction during movement.

The primary types of viscosupplementation include single-injection, three-injection, and five-injection viscosupplementation. Single-injection viscosupplementation involves a single shot of hyaluronic acid injected directly into the diarthrodial joints of a person's knees, aimed at restoring the rheological properties of the synovial fluid, thereby providing anti-inflammatory and analgesic effects. Hyaluronic acid, including both standard and stabilized forms, can be derived from avian and non-avian sources. These treatments are used to manage various osteoarthritides, including knee osteoarthritis, hip osteoarthritis, and hand osteoarthritis, and are administered in settings such as hospitals, ambulatory surgical centers, and others.

Tariffs have impacted the viscosupplementation market by increasing the cost of imported hyaluronic acid and related injectable components, leading to higher production and treatment costs. This disruption particularly affects single, three, and five injection types and regions heavily reliant on imports, such as North America and Europe. Hospitals and ambulatory surgical centers face cost pressures, while local manufacturing initiatives may see growth. Overall, tariffs are driving manufacturers to explore domestic sourcing and cost-efficient innovations.

The viscosupplementation market research report is one of a series of new reports from The Business Research Company that provides viscosupplementation market statistics, including viscosupplementation industry global market size, regional shares, competitors with a viscosupplementation market share, detailed viscosupplementation market segments, market trends and opportunities, and any further data you may need to thrive in the viscosupplementation industry. This viscosupplementation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The viscosupplementation market size has grown rapidly in recent years. It will grow from $4.5 billion in 2025 to $4.97 billion in 2026 at a compound annual growth rate (CAGR) of 10.4%. The growth in the historic period can be attributed to rising prevalence of osteoarthritis, increasing geriatric population, advancements in joint care therapies, growing awareness of viscosupplementation, expanding orthopedic healthcare infrastructure.

The viscosupplementation market size is expected to see rapid growth in the next few years. It will grow to $7.34 billion in 2030 at a compound annual growth rate (CAGR) of 10.2%. The growth in the forecast period can be attributed to adoption of regenerative medicine, integration of digital health monitoring, development of novel hyaluronic acid formulations, expansion of ambulatory surgical centers, rising investments in outpatient orthopedic procedures. Major trends in the forecast period include minimally invasive joint therapies, regenerative medicine integration, personalized osteoarthritis treatment, injectable hyaluronic acid innovations, outpatient orthopedic procedures.

The growing prevalence of osteoarthritis is expected to drive the expansion of the viscosupplementation market in the coming years. Osteoarthritis, a degenerative joint disease and a common form of arthritis, occurs when the joints, particularly in the hips, knees, and hands, begin to deteriorate. Viscosupplementation treatments help alleviate pain and facilitate smooth bone movement by injecting hyaluronic acid directly into the joints, reducing pain and improving joint functionality. For example, in August 2023, the Institute for Health Metrics and Evaluation (IHME), a U.S.-based nonprofit global health research center, reported that by 2050, osteoarthritis of the knee is expected to increase by 75%, and osteoarthritis of the hand by 50%. Therefore, the rising prevalence of osteoarthritis is driving the growth of the viscosupplementation market.

Leading companies in the viscosupplementation market are focusing on developing innovative products, such as resorbable hyaluronic acid scaffolds, to improve joint lubrication, promote tissue regeneration, and offer long-lasting relief from osteoarthritis symptoms, thereby enhancing patient outcomes and broadening treatment options. A resorbable hyaluronic acid scaffold is a biocompatible, biodegradable structure made from hyaluronic acid (HA), a naturally occurring polysaccharide in connective tissues. For instance, in May 2023, Anika Therapeutics, Inc., a U.S.-based company specializing in orthopedics, launched Hyalofast, a single-stage, off-the-shelf, resorbable hyaluronic acid scaffold for cartilage repair. Hyalofast provides a hyaluronic acid-based solution for joint preservation, potentially offering an alternative to more invasive surgical procedures.

In August 2025, Ono Pharmaceutical Co., Ltd., a Japan-based provider of pharmaceuticals and medical products, partnered with Seikagaku Corporation to co-develop and market Gel-One, a hyaluronic acid-based viscosupplement for osteoarthritis. Through this partnership, the companies aim to expand their presence in the Japanese viscosupplementation market by combining Seikagaku's product development and manufacturing expertise with Ono's marketing and distribution network. Seikagaku Corporation is a Japan-based developer and manufacturer of hyaluronic acid therapeutics, including injectable viscosupplements for joint health.

Major companies operating in the viscosupplementation market are Seikagaku Corporation, Anika Therapeutics Inc., Bioventus LLC, Zimmer Biomet, Johnson & Johnson Services Inc., Aptissen S.A., Smith & Nephew Plc., Flexion Therapeutics Inc., Regen Lab SA, OrthogenRx Inc., Fidia Farmaceutici S.P.A, Ferring Pharmaceuticals, Laboratoires VIVACY, Allergan, Hyalgan, Synvisc, Euflexxa, Sanofi S.A., Wellchem Pharmaceuticals Pte Ltd, Medtronic Inc.

North America was the largest region in the viscosupplementation market in 2025. The regions covered in the viscosupplementation market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the viscosupplementation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The viscosupplementation market consists of revenues earned by entities by providing viscosupplementation therapy services such as plasma-rich platelet (PRP) injections and stem cell injections that are used in osteoarthritis (OA) treatment procedures. The market value includes the value of related goods sold by the service provider or included within the service offering. The viscosupplementation market also includes sales of hyaluronans and hylan injection preparations to provide viscosupplementation therapy services. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Viscosupplementation Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses viscosupplementation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on end user analysis.
  • Benchmark performance against key competitors based on market share, innovation, and brand strength.
  • Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
  • Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for viscosupplementation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The viscosupplementation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
  • The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
  • The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
  • The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
  • The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
  • The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

  • Markets Covered:1) By Type: Single Injection Viscosupplementation; Three Injection Viscosupplementation; Five Injection Viscosupplementation
  • 2) By Source: Avian Origin; Non-Avian Origin
  • 3) By Hyaluronic Acids: Standard Hyaluronic Acid; Stabilized Hyaluronic Acid
  • 4) By Application: Knee Osteoarthritis; Hip Osteoarthritis; Hand Osteoarthritis
  • 5) By End-User: Hospitals; Ambulatory Surgical Centers; Other End-Users
  • Subsegments:
  • 1) By Single Injection Viscosupplementation: Hyaluronic Acid-Based Products; Non-Hyaluronic Acid Products
  • 2) By Three Injection Viscosupplementation: Hyaluronic Acid-Based Products; Combination Products
  • 3) By Five Injection Viscosupplementation: Hyaluronic Acid-Based Products; Combination Products
  • Companies Mentioned: Seikagaku Corporation; Anika Therapeutics Inc.; Bioventus LLC; Zimmer Biomet; Johnson & Johnson Services Inc.; Aptissen S.A.; Smith & Nephew Plc.; Flexion Therapeutics Inc.; Regen Lab SA; OrthogenRx Inc.; Fidia Farmaceutici S.P.A; Ferring Pharmaceuticals; Laboratoires VIVACY; Allergan; Hyalgan; Synvisc; Euflexxa; Sanofi S.A.; Wellchem Pharmaceuticals Pte Ltd; Medtronic Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: Word, PDF or Interactive Report
  • + Excel Dashboard
  • Added Benefits
  • Bi-Annual Data Update
  • Customisation
  • Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

  • 1.1. Key Market Insights (2020-2035)
  • 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
  • 1.3. Major Factors Driving the Market
  • 1.4. Top Three Trends Shaping the Market

2. Viscosupplementation Market Characteristics

  • 2.1. Market Definition & Scope
  • 2.2. Market Segmentations
  • 2.3. Overview of Key Products and Services
  • 2.4. Global Viscosupplementation Market Attractiveness Scoring And Analysis
    • 2.4.1. Overview of Market Attractiveness Framework
    • 2.4.2. Quantitative Scoring Methodology
    • 2.4.3. Factor-Wise Evaluation
  • Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
    • 2.4.4. Market Attractiveness Scoring and Interpretation
    • 2.4.5. Strategic Implications and Recommendations

3. Viscosupplementation Market Supply Chain Analysis

  • 3.1. Overview of the Supply Chain and Ecosystem
  • 3.2. List Of Key Raw Materials, Resources & Suppliers
  • 3.3. List Of Major Distributors and Channel Partners
  • 3.4. List Of Major End Users

4. Global Viscosupplementation Market Trends And Strategies

  • 4.1. Key Technologies & Future Trends
    • 4.1.1 Biotechnology, Genomics & Precision Medicine
    • 4.1.2 Industry 4.0 & Intelligent Manufacturing
    • 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
    • 4.1.4 Artificial Intelligence & Autonomous Intelligence
    • 4.1.5 Internet Of Things (Iot), Smart Infrastructure & Connected Ecosystems
  • 4.2. Major Trends
    • 4.2.1 Minimally Invasive Joint Therapies
    • 4.2.2 Regenerative Medicine Integration
    • 4.2.3 Personalized Osteoarthritis Treatment
    • 4.2.4 Injectable Hyaluronic Acid Innovations
    • 4.2.5 Outpatient Orthopedic Procedures

5. Viscosupplementation Market Analysis Of End Use Industries

  • 5.1 Hospitals
  • 5.2 Ambulatory Surgical Centers
  • 5.3 Orthopedic Clinics
  • 5.4 Rehabilitation Centers
  • 5.5 Sports Medicine Centers

6. Viscosupplementation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Viscosupplementation Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

  • 7.1. Global Viscosupplementation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 7.2. Global Viscosupplementation Market Size, Comparisons And Growth Rate Analysis
  • 7.3. Global Viscosupplementation Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
  • 7.4. Global Viscosupplementation Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Viscosupplementation Total Addressable Market (TAM) Analysis for the Market

  • 8.1. Definition and Scope of Total Addressable Market (TAM)
  • 8.2. Methodology and Assumptions
  • 8.3. Global Total Addressable Market (TAM) Estimation
  • 8.4. TAM vs. Current Market Size Analysis
  • 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Viscosupplementation Market Segmentation

  • 9.1. Global Viscosupplementation Market, Segmentation By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Single Injection Viscosupplementation, Three Injection Viscosupplementation, Five Injection Viscosupplementation
  • 9.2. Global Viscosupplementation Market, Segmentation By Source, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Avian Origin, Non-Avian Origin
  • 9.3. Global Viscosupplementation Market, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Standard Hyaluronic Acid, Stabilized Hyaluronic Acid
  • 9.4. Global Viscosupplementation Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Knee Osteoarthritis, Hip Osteoarthritis, Hand Osteoarthritis
  • 9.5. Global Viscosupplementation Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hospitals, Ambulatory Surgical Centers, Other End-Users
  • 9.6. Global Viscosupplementation Market, Sub-Segmentation Of Single Injection Viscosupplementation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hyaluronic Acid-Based Products, Non-Hyaluronic Acid Products
  • 9.7. Global Viscosupplementation Market, Sub-Segmentation Of Three Injection Viscosupplementation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hyaluronic Acid-Based Products, Combination Products
  • 9.8. Global Viscosupplementation Market, Sub-Segmentation Of Five Injection Viscosupplementation, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • Hyaluronic Acid-Based Products, Combination Products

10. Viscosupplementation Market Regional And Country Analysis

  • 10.1. Global Viscosupplementation Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
  • 10.2. Global Viscosupplementation Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Viscosupplementation Market

  • 11.1. Asia-Pacific Viscosupplementation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 11.2. Asia-Pacific Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Viscosupplementation Market

  • 12.1. China Viscosupplementation Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 12.2. China Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Viscosupplementation Market

  • 13.1. India Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Viscosupplementation Market

  • 14.1. Japan Viscosupplementation Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 14.2. Japan Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Viscosupplementation Market

  • 15.1. Australia Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Viscosupplementation Market

  • 16.1. Indonesia Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Viscosupplementation Market

  • 17.1. South Korea Viscosupplementation Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 17.2. South Korea Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Viscosupplementation Market

  • 18.1. Taiwan Viscosupplementation Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 18.2. Taiwan Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Viscosupplementation Market

  • 19.1. South East Asia Viscosupplementation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 19.2. South East Asia Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Viscosupplementation Market

  • 20.1. Western Europe Viscosupplementation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 20.2. Western Europe Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Viscosupplementation Market

  • 21.1. UK Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Viscosupplementation Market

  • 22.1. Germany Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Viscosupplementation Market

  • 23.1. France Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Viscosupplementation Market

  • 24.1. Italy Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Viscosupplementation Market

  • 25.1. Spain Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Viscosupplementation Market

  • 26.1. Eastern Europe Viscosupplementation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 26.2. Eastern Europe Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Viscosupplementation Market

  • 27.1. Russia Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Viscosupplementation Market

  • 28.1. North America Viscosupplementation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 28.2. North America Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Viscosupplementation Market

  • 29.1. USA Viscosupplementation Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 29.2. USA Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Viscosupplementation Market

  • 30.1. Canada Viscosupplementation Market Overview
  • Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 30.2. Canada Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Viscosupplementation Market

  • 31.1. South America Viscosupplementation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 31.2. South America Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Viscosupplementation Market

  • 32.1. Brazil Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Viscosupplementation Market

  • 33.1. Middle East Viscosupplementation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 33.2. Middle East Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Viscosupplementation Market

  • 34.1. Africa Viscosupplementation Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 34.2. Africa Viscosupplementation Market, Segmentation By Type, Segmentation By Source, Segmentation By Hyaluronic Acids, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Viscosupplementation Market Regulatory and Investment Landscape

36. Viscosupplementation Market Competitive Landscape And Company Profiles

  • 36.1. Viscosupplementation Market Competitive Landscape And Market Share 2024
    • 36.1.1. Top 10 Companies (Ranked by revenue/share)
  • 36.2. Viscosupplementation Market - Company Scoring Matrix
    • 36.2.1. Market Revenues
    • 36.2.2. Product Innovation Score
    • 36.2.3. Brand Recognition
  • 36.3. Viscosupplementation Market Company Profiles
    • 36.3.1. Seikagaku Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.2. Anika Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.3. Bioventus LLC Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.4. Zimmer Biomet Overview, Products and Services, Strategy and Financial Analysis
    • 36.3.5. Johnson & Johnson Services Inc. Overview, Products and Services, Strategy and Financial Analysis

37. Viscosupplementation Market Other Major And Innovative Companies

  • Aptissen S.A., Smith & Nephew Plc., Flexion Therapeutics Inc., Regen Lab SA, OrthogenRx Inc., Fidia Farmaceutici S.P.A, Ferring Pharmaceuticals, Laboratoires VIVACY, Allergan, Hyalgan, Synvisc, Euflexxa, Sanofi S.A., Wellchem Pharmaceuticals Pte Ltd, Medtronic Inc.

38. Global Viscosupplementation Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Viscosupplementation Market

40. Viscosupplementation Market High Potential Countries, Segments and Strategies

  • 40.1 Viscosupplementation Market In 2030 - Countries Offering Most New Opportunities
  • 40.2 Viscosupplementation Market In 2030 - Segments Offering Most New Opportunities
  • 40.3 Viscosupplementation Market In 2030 - Growth Strategies
    • 40.3.1 Market Trend Based Strategies
    • 40.3.2 Competitor Strategies

41. Appendix

  • 41.1. Abbreviations
  • 41.2. Currencies
  • 41.3. Historic And Forecast Inflation Rates
  • 41.4. Research Inquiries
  • 41.5. The Business Research Company
  • 41.6. Copyright And Disclaimer